Yantai Dongcheng Pharmaceutical GroupLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Zhi Gang Luo
Chief executive officer
CN¥2.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.3yrs |
| CEO ownership | 0.6% |
| Management average tenure | 4.3yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) Takes On Some Risk With Its Use Of Debt
Dec 19
Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) Has A Pretty Healthy Balance Sheet
Aug 23Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) Business Is Yet to Catch Up With Its Share Price
Jul 12News Flash: 7 Analysts Think Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SZSE:002675) Earnings Are Under Threat
May 06Yantai Dongcheng Pharmaceutical GroupLtd's (SZSE:002675) Problems Go Beyond Weak Profit
May 05Is Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) A Risky Investment?
Mar 15Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) P/E Is On The Mark
Feb 27CEO
Zhi Gang Luo (54 yo)
Mr. Zhi Gang Luo serves as a Non-Independent Director at Yantai Dongcheng Pharmaceutical Group Co., Ltd. since January 22, 2021 and serves as its General Manager. He was a Deputy General Manager at Yantai...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | no data | CN¥2.33m | 0.60% CN¥ 71.0m | |
| Financial Director | 17.4yrs | CN¥896.20k | 0.0052% CN¥ 624.4k | |
| Deputy GM | 5.6yrs | CN¥1.34m | no data | |
| Deputy General Manager | 3.1yrs | CN¥886.20k | 0.00038% CN¥ 45.3k | |
| Deputy General Manager | 2.4yrs | CN¥648.70k | no data | |
| Deputy General Manager | 4.3yrs | CN¥1.51m | no data | |
| Deputy General Manager | 4.3yrs | CN¥1.21m | no data | |
| Accounting Supervisor | no data | no data | no data |
Experienced Management: 002675's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | 4.3yrs | CN¥2.33m | 0.60% CN¥ 71.0m | |
| Deputy GM | 3yrs | CN¥1.34m | no data | |
| Independent Director | 4.3yrs | CN¥70.00k | no data | |
| Chairman | 11.3yrs | CN¥1.80m | 12.53% CN¥ 1.5b | |
| Supervisor | 11.3yrs | no data | 0.0020% CN¥ 240.7k | |
| Chairman of the Supervisory Board | no data | no data | no data | |
| Independent Director | 4.3yrs | CN¥70.00k | no data | |
| Supervisor | 3.1yrs | no data | no data |
Experienced Board: 002675's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/22 17:14 |
| End of Day Share Price | 2025/05/22 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yanyin Zhu | China International Capital Corporation Limited |
| Zhu Chen | Citic Securities Co., Ltd. |
| Mingrui Wang | Everbright Securities Co. Ltd. |